NUVB vs STOK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
STOK Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stoke Therapeutics, Inc. Common Stock (STOK) driven by superior Momentum & Technical, Options & Structure while NUVB counters with relative strength in Growth & Margin. Fundamentally, NUVB trades at N/M Forward P/E with -61.2% operating margin (+242.6% YoY revenue) versus STOK at N/M Forward P/E and -913.2% operating margin (+5.9% YoY). In options structure, NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against STOK sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NUVB Revenue | STOK Revenue | NUVB Op. Margin | STOK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | N/A | $10M | N/A | -841.2% | STOK |
| FY2023 | N/A | $10M | N/A | -1307.2% | STOK |
| FY2024 | $10M | $40M | -7527.3% | -277.3% | STOK |
| FY2025 | $60M | $180M | -338.7% | -11.2% | STOK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NUVB | STOK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.3B | $1.8B | Larger Scale | STOK |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +242.6% | +5.9% | Higher Growth | NUVB |
| Operating Margin (TTM) Profitability | -61.2% | -913.2% | Higher Margin | NUVB |
| Net Profit Margin Profitability | -67.4% | 0.0% | Higher Margin | STOK |
| Return on Equity (ROE) Capital Efficiency | -49.1% | -73.6% | Higher ROE | NUVB |
| 52-Week Range Position Momentum | 2% ($4โ$10) | 26% ($22โ$40) | Stronger Trend | STOK |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 55% Vol | 0.83ฮฒ ยท 38% Vol | Lower Realized Risk | STOK |
| Unified Institutional Score Composite Signal | 61.0 / 100 (BUY) | 55.9 / 100 (HOLD) | Higher Composite | NUVB |